net dbt
cash-flow catalyst-rich idea ad ci
case ci cash capabl consolid
ad ci list express script acquisit add capabl
cash-flow potenti ep upsid think ci could achiev close low end
pro forma ep target year earli catalyst ci includ express script
esrx deal close street estim move updat integr process
faster/larg expect capit deploy compel aspect
deal yield ci move distant fourth/fifth
group strong third much pf
combin despit trade discount vs peer ci look particularli
well posit build capabl buy back stock quickli de-lever
valuat reflect capabl growth
esrx deal would help ci lower cost close gap care compet effect
increasingli integr health plan pharmaci environ enhanc pharmaci
capabl integr data critic goal posit commentari
deal integr come month well receiv market
start becom comfort deal clear valuat
disconnect ci trade pf ep vs stand-alone prior deal
announc meanwhil diversifi averag remain multipl
could reach next year execut ci perform well think could
start close gap howev po
upsid potenti conserv repres pf earn power
focu free cash flow option
although pharmaci benefit manag pbm slower growth busi come
incred strong profil estim compani gener
core free cash flow per year allow debt paydown nearli share
repo/year bring debt cap back normal level end
top normal cash-flow expect ci gener anoth
one-tim cash expir esrx/antm contract next two year
note addit buy back healthi amount stock year ci like
key consolid health care servic sector next decad build
deeper govern busi broader servic platform includ consum
posit potenti risk
trend remain well control ci manag care organ
lower trend guidanc twice year signal confid strong meanwhil
expect preliminari medicar advantag rate show anoth strong year
rate ci bullish abil see acceler growth
rise interest rate yet anoth posit estim everi
increas ci invest incom yield could add ep although would take six
year fulli re-price far risk like continu nois around
potenti repeal afford act ci minim exposur final
singl payer rhetor could heat near presidenti elect
pass legisl unlik next decad
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
po base ep estim repres premium
five-year averag view appropri given outlook
risk po issu disabl life busi compani see higher
expect cost trend potenti impact futur regulatori chang star
rate continu deterior
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
invest opinion system contain end report head fundament equiti opinion dark grey shade indic secur restrict opinion suspend medium grey
shade indic secur review opinion withdrawn grey shade indic secur cover chart current novemb later date indic
equiti invest rate distribut health group sep
equiti invest rate distribut global group sep
issuer invest bank client bofa merril lynch one affili within past month purpos invest rate distribut coverag univers includ stock
stock rate neutral includ hold stock rate under-perform includ sell
fundament equiti opinion opinion includ volatil risk rate invest rate incom rate volatil risk rate indic potenti
price fluctuat medium high invest rate reflect analyst assess stock absolut total return potenti ii
attract invest rel stock within coverag cluster defin three invest rate buy stock expect total
return least attract stock coverag cluster neutral stock expect remain flat increas valu less attract
buy rate stock under-perform stock least attract stock coverag cluster analyst assign invest rate consid among thing
month total return expect stock firm guidelin rate dispers shown tabl current price object stock
referenc better understand total return expect given time price object reflect analyst view potenti price appreci depreci
total return expect within period date initi rate
rate dispers guidelin coverag cluster
rate dispers may vari time time bofa merril lynch research believ better reflect invest prospect stock coverag cluster
incom rate indic potenti cash dividend same/high dividend consid secur same/low dividend consid secur pay
cash dividend coverag cluster compris stock cover singl analyst two analyst share common industri sector region classif stock
coverag cluster includ recent bofa merril lynch report referenc stock
price chart secur referenc research report avail http //pricechart baml com call mail
mlpf one affili act market maker equiti secur recommend report cigna corp
issuer within last month invest bank client mlpf and/or one affili cigna corp
mlpf affili receiv compens issuer non-invest bank servic product within past month cigna corp
issuer within last month non-secur busi client mlpf and/or one affili cigna corp
mlpf affili receiv compens invest bank servic issuer within past month cigna corp
mlpf affili expect receiv intend seek compens invest bank servic issuer affili issuer within next three month cigna
mlpf one affili will sell buy client equiti secur issuer princip basi cigna corp
issuer within last month secur busi client non-invest bank mlpf and/or one affili cigna corp
bofa merril lynch research personnel includ analyst respons report receiv compens base upon among factor overal profit america
corpor includ profit deriv invest bank analyst respons report may also receiv compens base upon among factor overal
profit bank sale trade busi relat class secur financi instrument analyst respons
